The Agenda for the bi-weekly meeting tomorrow April 20th:
How to run the “Predicting outcomes for new users of celecoxib study” in R
Discusssion on best practices wiki page, e.g.,
a. How to divide in train test sets
b. How many folds for cross-validation? Is this dependent on the data size?
c. How to implement inclusion/exclusion correctly?
d. How to test sensitivity of model performance on user choices like cohort definition and exclusion criteria
e. Your input…
In the TC tomorrow Jenna will give a presentation about the Prognosis Research Strategy (PROGRESS) group and the Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD statement)
In the TC today Jenna will continue her presentation from last meeting about PROGRESS and the TRIPOD statement.
We hope the round up the best-practices discussion today. I have prepared an abstract for the OHDSI symposium during my flight to US to describe the work done so far on this. I will add any remaining points discussed today and will distribute it for your feedback.
Because of the face-to-face OHDSI meeting this Friday we will cancel the meeting of today.
Many team members are either travelling or under high workload at the moment and cannot join.
Since I am in Korea today and the TC will be in the middle of the night, Jenna will lead a discussion on possible research directions for the PLP workgroup.
Tomorrow we have the PLP WG TC on the agenda. Unfortunately, I am not available at that time due to a meeting in which I have to present on Patient-Level Prediction.
If there is someone in the group that likes to present their work or like to discuss research opportunities tomorrow let us know and Jenna can start the TC, otherwise we cancel the meeting at the end of today.